TAIKO PHARMACEUTICAL CO., LTD.
Manufactures OTC gastrointestinal medicine and leading infection control products.
4574 | T
Overview
Corporate Details
- ISIN(s):
- JP3442200006
- LEI:
- Country:
- Japan
- Address:
- 吹田市内本町三丁目３４番１４号
- Website:
- https://www.seirogan.co.jp/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Taiko Pharmaceutical Co., Ltd. is a manufacturer and distributor specializing in pharmaceuticals and infection control products. The company operates through three primary business segments: Pharmaceutical, Infection Control, and Others. Its Pharmaceutical division is centered on its flagship product, Seirogan, an over-the-counter gastrointestinal medication with a history of over 100 years, used for treating symptoms like diarrhea and loose stools. The Infection Control division, a significant contributor to company revenue, develops and markets products including a leading brand of airborne disinfectants. The company is engaged in ongoing research and development to support its product lines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-08 08:35 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2025-08-08 08:34 |
Interim Report
半期報告書－第80期(2025/01/01－2025/12/31)
|
Japanese | 197.8 KB | ||
| 2025-04-01 08:45 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 22.1 KB | ||
| 2025-03-28 07:36 |
Regulatory News Service
臨時報告書
|
Japanese | 19.1 KB | ||
| 2025-03-28 07:35 |
Governance Information
内部統制報告書－第79期(2024/01/01－2024/12/31)
|
Japanese | 22.1 KB | ||
| 2025-03-28 07:33 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2025-03-28 07:32 |
Annual Report
有価証券報告書－第79期(2024/01/01－2024/12/31)
|
Japanese | 1011.8 KB | ||
| 2024-08-09 08:34 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2024-08-09 08:33 |
Interim Report
半期報告書－第79期(2024/01/01－2024/12/31)
|
Japanese | 210.9 KB | ||
| 2024-05-10 08:37 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2024-05-10 08:35 |
Quarterly Report
四半期報告書－第79期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 164.9 KB | ||
| 2024-04-01 08:14 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 23.7 KB | ||
| 2024-03-28 07:30 |
Governance Information
内部統制報告書－第78期(2023/01/01－2023/12/31)
|
Japanese | 22.1 KB | ||
| 2024-03-28 07:28 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2024-03-28 07:26 |
Annual Report
有価証券報告書－第78期(2023/01/01－2023/12/31)
|
Japanese | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all TAIKO PHARMACEUTICAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TAIKO PHARMACEUTICAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TAIKO PHARMACEUTICAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
